Why We Need To Secure All Points Of Entry Into Our Country

On Thursday, The Epoch Times posted an article about a drug seizure at a Chicago air cargo facility.

The article reports:

Federal agents at a Chicago air cargo facility have seized shipments from China containing 18 pounds of xylazine, which is increasingly found in the U.S. illicit drug market.

The three shipments arrived on April 12 and were headed to residences in Cleveland and Philadelphia, Customs and Border Protection (CBP) announced in a statement on April 16.

“Drug traffickers are persistent in their attempts to smuggle sedatives such as xylazine into the United States, however, through our hard work and vigilance we will continue to intercept these dangerous substances at our port of entry before they can harm our communities,” LaFonda Sutton-Burke, director of field operation at the Chicago field office, said in a statement.

Xylazine, also known as “tranq” and the “zombie drug,” is a veterinary medication that acts as a sedative when administered to animals such as cattle, sheep, and horses during diagnostic and surgical procedures. Xylazine is not a controlled substance in the United States, but it is not approved for use on people, according to the U.S. Centers for Disease Control and Prevention.

Because of increased border security at America’s southern border, cartels and other drug smugglers are having to look for other ways to bring illegal drugs into America. We need to have drug-sniffing dogs at all points of entry.

The article notes:

The U.S. Drug Enforcement Administration (DEA) has warned that xylazine is making the deadly fentanyl crisis in the United States “even deadlier,” as fentanyl adulterated with xylazine has a longer-lasting psychoactive effect than fentanyl alone, increasing the risk of overdose death.

The Mexico-based Sinaloa and Jalisco cartels are known to be sourcing chemical precursors from China before these chemicals are manufactured into fentanyl. Last year, the House Select Committee on the Chinese Communist Party warned in a report that China-produced xylazines “are rapidly proliferating across the United States.”

The article concludes:

In recent years, some states have enacted laws to regulate the use of xylazine, including South Dakota, Pennsylvania, Ohio, and West Virginia.
A bipartisan group of lawmakers introduced the Combating Illicit Xylazine Act in both the House and the Senate in February. The legislation would make xylazine a Schedule III controlled substance while enabling the DEA to track its manufacturing to prevent any diversion to the illegal market.

“Illicit xylazine is contributing to the national drug epidemic and driving up overdose deaths in communities across the country,” Sen. Chuck Grassley (R-Iowa), who led the Senate bill with Sen. Catherine Cortez Masto (D-Nev.), said in a statement at the time.

“This bipartisan bill recognizes the lethal threat of xylazine and provides law enforcement new tools to combat its spread, while ensuring veterinarians, ranchers and cattlemen can continue to access the drug for legitimate animal treatment,” Grassley said.